医学
血瘀
按摩
中医药
随机对照试验
可视模拟标度
物理疗法
替代医学
月经
传统医学
观察研究
生活质量(医疗保健)
焦虑
内科学
病理
护理部
精神科
作者
Paphawarin Asawadethmetakul,Fangfang Xie,Chaoqun Xie,Jianwen Ma,Yanli You,Fei Yao
摘要
<b><i>Indroduction:</i></b> Primary dysmenorrhea (PD) is a very common issue in young women that reduces the quality of women’s lives. Both Western medicine and traditional Chinese medicine (TCM) provide several ways to treat PD; however, TCM treatment exhibits fewer side effects for the patient. Tuina massage and Chinese herbal compresses are considered forms of external TCM therapy that have been widely used to treat PD, especially in China. Therefore, to provide the most effective and safe treatment for PD, we combined Tuina and Chinese herbal compresses together in this observational study. <b><i>Methods:</i></b> A randomized controlled trial (RCT) consisting of 114 participants from the Shanghai University of Traditional Chinese Medicine who meet inclusion criteria will be divided into two groups in a 1:1 allocation ratio. The intervention group will receive Tuina combined with Chinese herbal compress therapy, while the control group will only receive Chinese herbal compress therapy. The treatment will be given 3 days before menstruation (once per day, 3 times per menstrual cycle). The primary outcome will be measured with the Visual Analog Scale (VAS). The secondary outcomes will be measured by the Dysmenorrhea Symptom Score, the Chinese Medical Dysmenorrhea Symptom Score, the Self-Rating Anxiety Scale (SAS), the Self-Rating Depression Scale (SDS), and the pain threshold at Guanyuan (<i>CV4</i>). <b><i>Conclusion:</i></b> This study will be the first RCT that will entail the combination of Tuina and Chinese herbal compresses to treat PD in the category of cold coagulation and blood stasis syndrome. If the results demonstrate that Tuina combined with a Chinese herbal compress is effective, we posit that this study will provide evidence-based references for a potential alternative treatment to treat PD in the future.
科研通智能强力驱动
Strongly Powered by AbleSci AI